| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 06/23/2011 | US20110152414 Insulating polymer material composition |
| 06/23/2011 | US20110152324 Therapeutic agents useful for treating pain |
| 06/23/2011 | US20110152293 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 06/23/2011 | US20110152241 Novel compounds as receptor modulators with therapeutic utility |
| 06/23/2011 | US20110152233 Pyrrolidine compounds |
| 06/23/2011 | US20110152232 Sulfonamide compounds and uses thereof |
| 06/23/2011 | US20110150833 Benzopyrans and analogs as rho kinase inhibitors |
| 06/23/2011 | US20110145970 Detection and use of low molecular-weight modulators of the cold-menthol receptor trpm8 |
| 06/23/2011 | CA2784830A1 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof |
| 06/23/2011 | CA2784662A1 Hepatitis c virus inhibitors |
| 06/23/2011 | CA2784528A1 Pyrrolidine carboxylic acid derivatives, pharmaceutical composition and methods for use in treating metabolic disorders as agonists of g-protein coupled receptor 43 (gpr43) |
| 06/23/2011 | CA2782601A1 Novel antiplatelet agent |
| 06/23/2011 | CA2782464A1 New ccr2 receptor antagonists and uses thereof |
| 06/23/2011 | CA2781495A1 Pyrrolidine derivatives |
| 06/23/2011 | CA2780526A1 Heterocyclic antiviral compounds |
| 06/22/2011 | EP2336124A1 Stable hydrate of a muscarinic receptor antagonist |
| 06/22/2011 | EP2336121A1 Fungicide n-cycloalkyl-carboxamide, thiocarboxamide and n-substituted-carboximidamide derivatives |
| 06/22/2011 | EP2336116A1 Process for the preparation of key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof |
| 06/22/2011 | EP2335701A1 Heterocyclic aspartyl protease inhibitors |
| 06/22/2011 | EP2335700A1 Hepatitis C virus polymerase inhibitors with a heterobicylic structure |
| 06/22/2011 | EP2334668A1 Process for preparing olmesartan medoxomil intermediate |
| 06/22/2011 | EP2334667A1 A process for preparation of rosuvastatin acetonide calcium |
| 06/22/2011 | EP2334664A1 1h-benzimidazole-5-carboxamides as anti-inflammatory agents |
| 06/22/2011 | EP2334662A1 Pyrine or pyrazine derivatives for treating hcv |
| 06/22/2011 | EP2334652A1 1h-benz imidazole-5-carboxamides as anti-inflammatory agents |
| 06/22/2011 | EP2334646A2 Substituted benzamides as cannabinoid receptor ligands |
| 06/22/2011 | EP2334183A1 Sulfonamide derivative metabotropic glutamate r4 ligands |
| 06/22/2011 | EP2102157B1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 06/22/2011 | EP2091924B1 Pyrimidine derivatives and their use as pesticides |
| 06/22/2011 | EP1856110B1 Oxyindole derivatives as 5ht4 receptor agonists |
| 06/22/2011 | CN1984905B Constrained himbacine analogs as thrombin receptor antagonists |
| 06/22/2011 | CN1898244B Triazole derivatives as vasopressin antagonists |
| 06/22/2011 | CN1867565B Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes |
| 06/22/2011 | CN1845734B Benzimidazole derivatives and their use as protein kinases inhibitors |
| 06/22/2011 | CN102105934A Coloring matter for optical information recording medium and optical information recording medium |
| 06/22/2011 | CN102105462A Amidophenoxyindazoles useful as inhibitors of C-MET |
| 06/22/2011 | CN102105452A Substituted carbinol compound having cyclic linker |
| 06/22/2011 | CN102105451A Glucokinase activators |
| 06/22/2011 | CN102105437A Adamantyl diamide derivatives and uses of same |
| 06/22/2011 | CN102102015A Coumarin derivative type organic electroluminescent material and preparation method and applications thereof |
| 06/22/2011 | CN102101852A Coumarin derivates, preparation method thereof and application thereof in white-light organic electroluminescent device |
| 06/22/2011 | CN101633645B N3 alkylated benzimidazole derivatives as mek inhibitors |
| 06/22/2011 | CN101575333B Quinazoline derivatives and medical application thereof |
| 06/22/2011 | CN101560206B Intermediate of pemetrexed disodium, preparation method thereof and method for preparing pemetrexed disodium thereby |
| 06/22/2011 | CN101175747B Substituted N-arylpyrrolidines as selective androgen receptor modulators |
| 06/22/2011 | CN101108847B (+) doxazosin mesylate, method of manufacturing the same and use thereof |
| 06/22/2011 | CN101006055B 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase iepsilon |
| 06/21/2011 | USRE42477 Carboxylic acid derivatives, their preparation and use |
| 06/21/2011 | US7964727 N-({1-[(cis-1,4-dihydroxycyclohexyl)methyl]piperidin-4-yl}methyl)-1-isopropyl-5-methyl-2-oxo-1, 2-dihydroquinoline-3-carboxamide ethanedioate; gastroesophageal reflux disease, non-ulcer dyspepsia, functional dyspepsia, irritable bowel syndrome |
| 06/21/2011 | US7964646 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/21/2011 | US7964592 2,4-di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 06/21/2011 | US7964531 3-phenoxy-4-pyridazinol derivatives and herbicidal composition containing the same |
| 06/21/2011 | CA2676898C Ketal amide compounds, methods of making, and applications |
| 06/21/2011 | CA2649403C Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators |
| 06/21/2011 | CA2577144C Alkynyl compounds as non-nucleoside reverse transcriptase inhibitors |
| 06/21/2011 | CA2495386C Protein kinase inhibitors and uses thereof |
| 06/21/2011 | CA2483303C Cinnamic acid amides |
| 06/21/2011 | CA2474192C Nicotinamide derivates useful as p38 inhibitors |
| 06/21/2011 | CA2473468C Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 06/21/2011 | CA2442114C N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
| 06/21/2011 | CA2359115C Acyl derivatives which treat vla-4 related disorders |
| 06/16/2011 | WO2011072241A1 4 -oxo- ih -quinoline- 3 - carboxamides as modulators of atp -binding cassette transporters |
| 06/16/2011 | WO2011072174A1 Therapeutically active compounds for use in the treatment of cancer characterized as having an idh mutation |
| 06/16/2011 | WO2011071255A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 06/16/2011 | WO2011071136A1 Therapeutic agent for fibromyalgia |
| 06/16/2011 | WO2011071095A1 Benzamide compound |
| 06/16/2011 | WO2011071048A1 Heteroarylcarboxylic acid ester derivative |
| 06/16/2011 | WO2011070771A1 Azole derivatives, methods for producing the same, intermediate thereof, agro-horticultural agents |
| 06/16/2011 | WO2011070539A1 Cysteine protease inhibitors |
| 06/16/2011 | WO2011070459A1 Process for enantiomerically pure 8-aryloctanoic acids as aliskiren |
| 06/16/2011 | WO2011070419A1 An improved process for the preparation of darifenacin hydrobromide |
| 06/16/2011 | WO2011070131A1 5-amino- 4-hydroxypentoyl amides |
| 06/16/2011 | WO2011069916A1 Triazole compounds, use thereof as a fungicide, and agents comprising same |
| 06/16/2011 | WO2011069912A1 Triazole compounds, use thereof and agents containing said compounds |
| 06/16/2011 | WO2011069894A1 Triazole compounds, use thereof, and agents containing same |
| 06/16/2011 | WO2011021726A3 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation |
| 06/16/2011 | US20110144332 Pyrazole compounds that modulate hsp90 activity |
| 06/16/2011 | US20110144330 2,4-Pyrimidinediamine Compounds and their Uses |
| 06/16/2011 | US20110144169 Inhibitors of cellular necrosis |
| 06/16/2011 | US20110144163 Thiolated paclitaxels for reaction with gold nanoparticles as drug delivery agents |
| 06/16/2011 | US20110144153 Amide compound |
| 06/16/2011 | US20110144106 Novel cyclopropane indolinone derivatives |
| 06/16/2011 | US20110144103 Pyrrole compounds that modulate hsp90 activity |
| 06/16/2011 | US20110144101 Macrocyclic compounds useful as pharmaceuticals |
| 06/16/2011 | US20110144096 Treating various disorders using trkb agonists |
| 06/16/2011 | US20110144094 Heterocyclic tetracyclic tetrahydrofuran derivatives |
| 06/16/2011 | US20110144090 Compounds and methods of use thereof |
| 06/16/2011 | US20110144081 Pyrrolidine derivatives |
| 06/16/2011 | US20110144075 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 06/16/2011 | US20110144070 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 06/16/2011 | US20110144068 3,4-diarylpyrazoles as protein kinase inhibitors |
| 06/16/2011 | US20110144060 Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methods |
| 06/16/2011 | US20110143942 Pyrazolyl-Substituted Heterocycles and Their Use as Phytosanitary Products |
| 06/16/2011 | US20110143939 Quinoxalin-2-one derivatives, compositions which protect useful plants and comprise these derivatives, and processes for their preparation and their use |
| 06/16/2011 | CA2783929A1 5-amino-4-hydroxypentoyl amides |
| 06/16/2011 | CA2783552A1 Azole derivatives, methods for producing the same, intermediate thereof, agro-horticultural agents |
| 06/16/2011 | CA2783537A1 Benzamide compound |
| 06/16/2011 | CA2783314A1 4-oxo-1h-quinoline-3-carboxamides as modulators of atp-binding cassette transporters |
| 06/16/2011 | CA2782292A1 Cysteine protease inhibitors |
| 06/15/2011 | EP2332924A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |